rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Boston Scientific Corporation

BSX · NYSE

Health CareMedical DevicesNot moving yet

BSX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 11.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$20.1M
Insider sales, 12 months
$39.4M
Officials’ trades on record
144

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$28.3M$0$16.8MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

144 disclosed lines: House 100, Senate 7, executive 37; 27 people.

WhoDidAmountTraded
Kevin Hern House: U.S. House ClerkOK01soldjoint$50k–$100k9 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01soldjoint$50k–$100k4 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01solddependent child$1k–$15k3 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01solddependent child$1k–$15k3 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01solddependent child$1k–$15k3 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01soldjoint$15k–$50k31 Aug 2026filed 25 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k28 Aug 2026filed 8 Oct 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k18 Aug 2026filed 10 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k17 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k10 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k27 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k24 Jul 2026filed 22 Sep 2026

Insiders

Buy orders, 12 months10
Sale orders, 12 months6
Buyers · sellers5 · 4
WhoDidSharesTraded
Susan E. MoranoDirectorbought2,040at $49.2225 Aug 2026filed 26 Aug 2026
David C. HabigerDirectorbought2,100at $47.595 Aug 2026filed 7 Aug 2026
David C. HabigerDirectorbought140at $48.594 Aug 2026filed 5 Aug 2026
Michael F. MahoneyChairman, President & CEObought186,240at $48.333 Aug 2026filed 5 Aug 2026
David C. HabigerDirectorbought1,042at $48.073 Aug 2026filed 5 Aug 2026
Edward J. LudwigDirectorbought5,000at $45.4831 Jul 2026filed 3 Aug 2026
David C. HabigerDirectorbought2,250at $55.9220 May 2026filed 21 May 2026
Edward J. LudwigDirectorbought3,580at $56.6820 May 2026filed 21 May 2026
Cheryl PegusDirectorbought1,770at $56.4920 May 2026filed 21 May 2026
David C. HabigerDirectorbought2,200at $56.9519 May 2026filed 21 May 2026
Michael F. MahoneyChairman, President & CEOsold1,200at $94.062 Feb 2026filed 3 Feb 2026
Michael F. MahoneyChairman, President & CEOsold159,701at $93.492 Feb 2026filed 3 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

News

Everyone who traded it

Kevin Hern HouseOK01 · last 9 Sep 20265 · 7
Padraig Andrew O'Connor Company insiderEVP, Global Operations · last 2 Sep 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 28 Aug 202618 · 15
Susan E. Morano Company insiderDirector · last 25 Aug 20261 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 18 Aug 202610 · 9
Emily Woodworth Company insiderSVP, Global Controller and CAO · last 11 Aug 20260 · 4
Jonathan Monson Company insiderEVP and CFO · last 10 Aug 20260 · 5
David C. Habiger Company insiderDirector · last 5 Aug 20265 · 0
Michael F. Mahoney Company insiderChairman, President & CEO · last 3 Aug 20263 · 29
Edward J. Ludwig Company insiderDirector · last 31 Jul 20263 · 6
Joseph Michael Fitzgerald Company insiderEVP & Group Pres, Cardiology · last 31 Jul 20261 · 26
John Boozman SenateSenator · last 4 Jun 20261 · 2

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202569.0%
Operating profit marginFY 2025 · to 31 Dec 202518.0%
Free cash flow marginFY 2025 · to 31 Dec 202518.2%
Return on capital employedFY 2025 · to 31 Dec 20259.4%
Debt to equityFY 2025 · to 31 Dec 20250.01×
Interest coverFY 2025 · to 31 Dec 202510.35×
Share count trendFY 2025 · to 30 Jan 2026-0.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.0B
Free cash flowFY 2025 · to 31 Dec 2025$3.7B

Analyst forecasts

No analyst forecasts yet.